Infections à Vibrio : Questions médicales fréquentes
Nom anglais: Vibrio Infections
Descriptor UI:D014735
Tree Number:C01.150.252.400.959
Termes MeSH sélectionnés :
Neoplasm Recurrence, Local
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à Vibrio : Questions médicales les plus fréquentes",
"headline": "Infections à Vibrio : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à Vibrio"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections bactériennes à Gram négatif",
"url": "https://questionsmedicales.fr/mesh/D016905",
"about": {
"@type": "MedicalCondition",
"name": "Infections bactériennes à Gram négatif",
"code": {
"@type": "MedicalCode",
"code": "D016905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Choléra",
"alternateName": "Cholera",
"url": "https://questionsmedicales.fr/mesh/D002771",
"about": {
"@type": "MedicalCondition",
"name": "Choléra",
"code": {
"@type": "MedicalCode",
"code": "D002771",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.400.959.347"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Infections à Vibrio",
"alternateName": "Vibrio Infections",
"code": {
"@type": "MedicalCode",
"code": "D014735",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bo Peng",
"url": "https://questionsmedicales.fr/author/Bo%20Peng",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocontrol, Guangdong Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China. Electronic address: pengb26@mail.sysu.edu.cn."
}
},
{
"@type": "Person",
"name": "Fei Li",
"url": "https://questionsmedicales.fr/author/Fei%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science and Technology, Beijing University of Chemical Technology, China; Clinical Laboratory center, Taian City Central Hospital, Taian 271000, China."
}
},
{
"@type": "Person",
"name": "Yigang Tong",
"url": "https://questionsmedicales.fr/author/Yigang%20Tong",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science and Technology, Beijing University of Chemical Technology, China. Electronic address: tong.yigang@gmail.com."
}
},
{
"@type": "Person",
"name": "Jaime Martinez-Urtaza",
"url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza",
"affiliation": {
"@type": "Organization",
"name": "Department de Genetica I de Microbiologia, Facultat de Biociencies, Universitat Autonoma de Barcelona, Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "C H Ding",
"url": "https://questionsmedicales.fr/author/C%20H%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology & Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer.",
"datePublished": "2024-08-20",
"url": "https://questionsmedicales.fr/article/39164626",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-024-12799-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36720507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1759-7714.14805"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a consensus-based delineation guideline for locally recurrent rectal cancer.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36410547",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.radonc.2022.11.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35939185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-022-06680-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.",
"datePublished": "2022-05-29",
"url": "https://questionsmedicales.fr/article/35643422",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-022-09650-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram négatif",
"item": "https://questionsmedicales.fr/mesh/D016905"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Vibrio",
"item": "https://questionsmedicales.fr/mesh/D014735"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à Vibrio - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à Vibrio",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à Vibrio",
"description": "Comment diagnostique-t-on une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer sans culture ?\nLes antécédents de voyage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à Vibrio",
"description": "Quels sont les symptômes courants d'une infection à Vibrio ?\nLes infections à Vibrio causent-elles des éruptions cutanées ?\nY a-t-il des symptômes graves à surveiller ?\nLes symptômes varient-ils selon la souche de Vibrio ?\nLes symptômes apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à Vibrio",
"description": "Comment prévenir les infections à Vibrio ?\nLa cuisson des fruits de mer est-elle suffisante ?\nL'eau potable est-elle un risque ?\nLes voyages en zones à risque nécessitent-ils des précautions ?\nLes personnes à risque doivent-elles être plus prudentes ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à Vibrio",
"description": "Quel est le traitement principal pour les infections à Vibrio ?\nLes antibiotiques sont-ils toujours nécessaires ?\nComment la déshydratation est-elle traitée ?\nY a-t-il des traitements préventifs ?\nLes probiotiques aident-ils dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à Vibrio",
"description": "Quelles sont les complications possibles des infections à Vibrio ?\nLes infections cutanées peuvent-elles s'aggraver ?\nY a-t-il un risque de septicémie ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à Vibrio",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies chroniques augmentent-elles le risque ?\nLa saison influence-t-elle le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à Vibrio ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures de selles et des tests sérologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cultures bactériennes et des tests PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic, mais des tests sont nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer sans culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des méthodes moléculaires comme la PCR peuvent être utilisées sans culture."
}
},
{
"@type": "Question",
"name": "Les antécédents de voyage sont-ils importants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents de consommation de fruits de mer ou de baignade en eau contaminée sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection à Vibrio ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections à Vibrio causent-elles des éruptions cutanées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines souches peuvent provoquer des infections cutanées, surtout après exposition à l'eau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent déshydratation sévère et choc septique, nécessitant une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la souche de Vibrio ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche, comme Vibrio cholerae ou Vibrio parahaemolyticus."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à Vibrio ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de consommer des fruits de mer crus et lavez-vous les mains régulièrement."
}
},
{
"@type": "Question",
"name": "La cuisson des fruits de mer est-elle suffisante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cuire les fruits de mer à des températures appropriées tue les bactéries Vibrio."
}
},
{
"@type": "Question",
"name": "L'eau potable est-elle un risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eau non traitée peut être contaminée, évitez de boire de l'eau non purifiée."
}
},
{
"@type": "Question",
"name": "Les voyages en zones à risque nécessitent-ils des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé de prendre des précautions alimentaires et d'hygiène lors de voyages."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être plus prudentes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées doivent éviter les fruits de mer crus et les eaux contaminées."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections à Vibrio ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la réhydratation, souvent accompagné d'antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils toujours nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas toujours nécessaires, surtout pour les infections légères."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation est-elle traitée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins existent pour certaines souches, mais leur utilisation est limitée."
}
},
{
"@type": "Question",
"name": "Les probiotiques aident-ils dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections à Vibrio ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la déshydratation sévère, le choc septique et des infections systémiques."
}
},
{
"@type": "Question",
"name": "Les infections cutanées peuvent-elles s'aggraver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections cutanées peuvent s'aggraver et nécessiter des soins médicaux urgents."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de septicémie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Vibrio peuvent provoquer une septicémie, surtout chez les personnes vulnérables."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une prise en charge médicale rapide, souvent en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'exposition à des eaux contaminées."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des infections graves."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques comme le diabète augmentent le risque d'infections à Vibrio."
}
},
{
"@type": "Question",
"name": "La saison influence-t-elle le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'infection augmente pendant les mois chauds, favorisant la prolifération de Vibrio."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Vibrio est endémique augmente le risque d'infection."
}
}
]
}
]
}
Local recurrence is common after curative resections of rectal cancer. Surgical resection is considered a primary curative treatment option for patients with locally recurrent rectal cancer (LRRC). LR...
From April 2010 to March 2022, a total of 166 patients underwent surgery for LRRC in the pelvic region at our institutions. Clinicopathological background and VTE incidence were compared retrospective...
Among the 166 patients included in the study, 55 patients (33.1%) needed sacral resection. Pharmacological prophylaxis for prevention of VTE was performed in 121 patients (73.3%), and the incidence of...
This study demonstrates that surgery for LRRC combined with sacral resection could be a significant risk factor for VTE....
The effectiveness of local therapy has been reported in patients with oligo-recurrence of non-small cell lung cancer (NSCLC), a metachronous recurrence with a limited number of recurrences, which can ...
From 2004 to 2014, 811 patients underwent complete resection for NSCLC at Kitasato University Hospital and, of these, 244 patients developed recurrence. Oligo-recurrence was defined as the presence of...
We retrospectively examined and compared the effects of EGFR-TKIs with those of radical local therapy in patients with oligo-recurrent EGFR-mutated NSCLC. The five-year post-recurrence survival (PRS) ...
Radical local therapy did not affect PRS in patients with oligo-recurrent EGFR-mutated NSCLC. Even in cases of oligo-recurrence, the administration of local therapy in patients with EGFR-mutated NSCLC...
Neoadjuvant chemoradiotherapy (nCRT) is used in locally recurrent rectal cancer (LRRC) to increase chances of a radical surgical resection. Delineation in LRRC is hampered by complex disease presentat...
Eight radiation oncologists, from Dutch and Swedish expert centres, participated in two meetings, delineating GTV and CTV in six cases. Regions at-risk for re-recurrence or irradical resection were id...
Inter-observer variation in delineation of LRRC appeared large. Multidisciplinary evaluation per case is beneficial in determining target volumes. The following consensus regarding target volumes was ...
This study provides a first consensus-based delineation guideline for LRRC. Analyses of re-recurrences is needed to understand disease behaviour and to optimize delineation guidelines accordingly....
Describes the relevance of -various classification methods for ipsilateral breast tumour recurrence (IBTR) as either true recurrence (TR) or new primary (NP) on both disease-specific survival (DSS) an...
Two hundred and thirty-four of 4359 women undergoing breast-conserving therapy experienced IBTR. We compared the impact of four known classification methods and two newly created classification method...
For three of the methods, a better DSS was observed for NP compared to TR with the hazard ratio (HR) ranging from 0.5 to 0.6. The new Twente method classification, comprising all classification criter...
IBTR classified as TR or NP has a prognostic value for both DSS and DMFS, but depends on the classification method used. Developing and validating a generally accepted form of classification are imper...
The international consensus guidelines for intraductal papillary mucinous neoplasm of the pancreas (IPMN) presented clinical features as indications for surgery. Whereas surveillance for recurrence, i...
This study aimed to assess the clinical features of recurrence at the remnant pancreas (Rem-Panc) and extra-pancreas (Ex-Panc) after surgery for IPMN. Ninety-one patients of IPMN that underwent detail...
The IPMNs were finally diagnosed as low-grade dysplasia (LDA, n = 42), high-grade dysplasia (HAD, n = 19), and invasive carcinoma (IPMC, n = 30). Recurrence was observed in 26 patients (29%), of which...
The risk factors for Rem-Panc and Ex-Panc recurrence differ. Therefore, optimal surveillance on these features is desirable to ensure that repeat pancreatectomy for Rem-Panc recurrence can be an appro...
Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months. The magnetic resonance spectroscopy imaging (MRSI) has been used for the detection of brain tumor...
The research was performed in accordance with the preferred reporting items for systematic review and meta-analysis guidelines. International electronic databases including 15 English sources were inv...
Nine studies were enrolled in the meta-analysis with a total of 354 patients (203 male and 151 female) whose average age ranged from 4 to 74 years. Anbarloui et al., Elias et al., Nemattalla et al., S...
MR spectroscopy is effective in distinguishing recurrent brain tumors from necrosis. Our meta-analysis revealed that Cho/NAA, Cho/Cr, and NAA/Cr ratios were significantly better predictor of detected ...
Despite multimodal therapy 5-15% of patients who undergo resection for advanced rectal cancer (LARC) will develop local recurrence. Management of locally recurrent rectal cancer (LRRC) presents a sign...
A systematic review was carried out searching MEDLINE, EMBASE and COCHRANE Trials database for all studies assessing pathological factors influencing survival following pelvic exenteration for LARC or...
Nine cohort studies met inclusion criteria, reporting outcomes for 2864 patients. Meta-analysis was not possible due to significant heterogeneity of reported outcomes. Resection margin status and noda...
Pathological resection margin status is widely demonstrated to influence disease free and overall survival following pelvic exenteration for rectal cancer. With increasing R0 rates, other adverse tumo...
Local recurrent brain metastases are defined as lesions that recur in the brain at the same site after a previous local therapy. In patients already submitted to surgery, a second operation may be pot...
37 patients submitted to surgery for a local, histologically confirmed, recurrent brain metastases between 2000 and 2022 were retrospectively analyzed with respect to the following parameters: age, hi...
A significant improvement of post-operative KPS status was obtained after second surgery. At multivariate analysis better results in terms of OS were achieved in patients with a pre-operative KPS ≥ 70...
Surgical resection of local recurrent brain metastases may improve patients ́ neurologic conditions allowing more time for systemic therapies to act with a low incidence of surgery-related morbidity a...
The management of locally recurrent gynecological carcinoma remains a challenge due to the limited availability of data. This study aims to share our institutional experience in using definitive radio...
The study retrospectively reviewed 20 patients in our hospital completing salvage 3D image-based HDR brachytherapy, with or without EBRT, for locally recurrent cervical and endometrial carcinoma after...
During a median observation period of 21 months, the study reported a tumor objective response rate of 95%. The 3-year DFS and OS rates were 89.4% and 90.9%, respectively. The EBRT combined with brach...
3D image-guided brachytherapy combined with EBRT shows effective tumor control and acceptable toxicity profile for women with locally recurrent gynecologic cancer. The success in managing vaginal recu...
The availability of high-quality patient-reported outcome (PRO) data is crucial to guiding shared decision-making in the context of locally recurrent rectal cancer (LRRC), where potential treatment be...
PubMed, Embase and CINAHL databases were searched, including studies published up until 14...
Thirty-five studies including 1914 patients with LRRC were identified. None of the studies included in the review met all eleven criteria for the quality of reporting of PROMs. Seventeen PROMs and two...
None of the PROMs which are currently being used to report PROs in LRRC have been validated for use in this cohort of patients. Future studies in this disease area should focus on utilising PROMs that...
